4//SEC Filing
Cavanaugh Stefanie L. 4
Accession 0001641172-25-013811
CIK 0000926617other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:15 PM ET
Size
7.8 KB
Accession
0001641172-25-013811
Insider Transaction Report
Form 4
Cavanaugh Stefanie L.
Director
Transactions
- Exercise/Conversion
Common Stock
2025-06-04+5,937→ 78,726 total - Exercise/Conversion
Restricted Stock Units
2025-06-04−5,937→ 0 total→ Common Stock (5,937 underlying)
Footnotes (3)
- [F1]Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 23,750 RSUs, 5,937 of which vested on June 4, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.
- [F2]Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock
- [F3]On August 22, 2024, the reporting person was granted 23,750 RSUs, 5,937 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4.
Documents
Issuer
Aspira Women's Health Inc.
CIK 0000926617
Entity typeother
Related Parties
1- filerCIK 0001688530
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 4:15 PM ET
- Size
- 7.8 KB